BTG Overview
- Year Founded
-
1948
- Status
-
Acquired/Merged
- Employees
-
1,600
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
21
BTG General Information
Description
BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. The revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.
Contact Information
Website
btgplc.comCorporate Office
- 300 Boston Scientific Way
- Marlborough, MA 01752
- United States
Corporate Office
- 300 Boston Scientific Way
- Marlborough, MA 01752
- United States
BTG Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BTG Comparisons
Industry
Financing
Details
BTG Competitors (15)
One of BTG’s 15 competitors is Lupin, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lupin | Corporation | Mumbai, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India |
BTG Patents
BTG Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026524951-A | How to use iloprost for treating frostbite | Pending | 18-Jul-2023 | ||
| EP-4746889-A1 | Method of using iloprost for treating frostbite | Pending | 18-Jul-2023 | ||
| US-12409183-B2 | Method of using iloprost for treating frostbite | Active | 18-Jul-2023 | ||
| US-20250099484-A1 | Method of using iloprost for treating frostbite | Active | 18-Jul-2023 | ||
| US-20260000680-A1 | Method of using iloprost for treating frostbite | Pending | 18-Jul-2023 | A61K31/5578 |
BTG Signals
BTG Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BTG Investments & Acquisitions (21)
BTG’s most recent deal was a Merger/Acquisition with Opy Health. The deal was made on 15-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Opy Health | 15-Aug-2023 | Merger/Acquisition | Other Healthcare Services | ||
| FCamara Consultoria | 04-Jul-2022 | Later Stage VC | IT Consulting and Outsourcing | ||
| Newrite Medical | 18-Jul-2019 | Early Stage VC | Drug Discovery | ||
| Veran Medical Technologies | 13-Nov-2018 | Later Stage VC | Diagnostic Equipment | ||
| NOvate Medical Technologies | 07-Sep-2018 | Merger/Acquisition | Other Devices and Supplies |
BTG Exits (8)
BTG’s most recent exit was on 13-Nov-2018 from Veran Medical Technologies. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Veran Medical Technologies | 13-Nov-2018 | Completed |
|
||
| Xention | 23-Nov-2010 | Completed |
|
||
| Avera Pharmaceuticals | 16-Jan-2008 | Completed |
|
||
| Xention | 18-Jul-2005 | Completed |
|
||
| Mesophotonics | 29-Jan-2004 | Early Stage VC | Completed |
|
BTG Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Opy Health | Sao Paulo, Brazil | 2020 | |
| BTG Ventures | London, United Kingdom | 2000 | |
| Galil Medical | Saint Paul, MN | 1997 | |
| Protherics | Runcorn, United Kingdom | 1987 | |
| Biocompatibles International | Farnham, United Kingdom | 1984 |
BTG FAQs
-
When was BTG founded?
BTG was founded in 1948.
-
Where is BTG headquartered?
BTG is headquartered in Marlborough, MA.
-
What is the size of BTG?
BTG has 1,600 total employees.
-
What industry is BTG in?
BTG’s primary industry is Discovery Tools (Healthcare).
-
Is BTG a private or public company?
BTG is a Private company.
-
What is the current valuation of BTG?
The current valuation of BTG is .
-
What is BTG’s current revenue?
The current revenue for BTG is .
-
How much funding has BTG raised over time?
BTG has raised $162M.
-
Who are BTG’s investors?
Cinven, Department for International Trade, and Novo Holdings have invested in BTG.
-
Who are BTG’s competitors?
Lupin, Glenmark Pharmaceuticals, Novartis, Evonile Pharma, and Biocon are some of the 15 competitors of BTG.
-
When was BTG acquired?
BTG was acquired on 19-Aug-2019.
-
Who acquired BTG?
BTG was acquired by Boston Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process